Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of The American Academy of Dermatology"
DOI: 10.1016/j.jaad.2020.03.033
Abstract: Background Registry studies broadly describing the safety of systemic drugs in psoriasis are needed. Objective To describe the safety findings of the systemic drugs acitretin, adalimumab, apremilast, cyclosporine, etanercept, infliximab, methotrexate, secukinumab, and ustekinumab used…
read more here.
Keywords:
registry;
registry adverse;
psoriasis;
adverse events ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Medicina Clinica"
DOI: 10.1016/j.medcle.2019.11.010
Abstract: Abstract Background and objective Myelofibrosis is an infrequent chronic myeloproliferative neoplasm. We aimed to describe the clinico-biological characteristics, treatment, and evolutive course of myelofibrosis patients in Spain. Material and methods A total of 1000 patients…
read more here.
Keywords:
clinico biological;
myelofibrosis;
biological characteristics;
spanish registry ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Endocrine Connections"
DOI: 10.1530/ec-19-0321
Abstract: Primary hyperparathyroidism is the most frequent manifestation of multiple endocrine neoplasia type 1 (MEN1) syndrome. Bone and renal complications are common. Surgery is the treatment of choice, but the best timing for surgery is controversial…
read more here.
Keywords:
surgical outcomes;
hyperparathyroidism;
primary hyperparathyroidism;
spanish registry ... See more keywords